Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

High Nu.Q® Vet Cancer Test Result Guide

Wednesday, October 8, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Volition has submitted a manuscript for the Nu.Q® Vet Cancer Test in cats, which is anticipated to be published in a peer-reviewed journal. This publication could trigger a $5 million milestone payment. Additionally, the company has developed the first automated version of this test in collaboration with Fujifilm Vet Systems.
Price reaction · baseline $13 (2025-10-07 close) · hit pre-market · 2 other VNRX headline(s) in the window, move may be shared
day 0 close
-0.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Submission of manuscript for Nu.Q® Vet Cancer Test in cats.
  • Potential to unlock a $5 million milestone payment.
  • First automated Nu.Q® Vet Cancer Test developed with Fujifilm Vet Systems.

Full Press Release Details

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is a diagnostic tool for detecting cancer in pets.

What milestone payment is associated with the Nu.Q® test?

The publication of the study is expected to unlock a $5 million milestone payment.

Who collaborated with Volition on the Nu.Q® test?

Volition collaborated with Fujifilm Vet Systems to develop the first automated Nu.Q® test.

In which species is the Nu.Q® test being studied?

The Nu.Q® Vet Cancer Test is currently being studied in cats.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Nu.Q® Veterinary Cancer Test Fujifilm Milestone Payment
Last updated: Oct 8, 2025

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk